Pfizer Inc

Pfizer acquires Icagen

Pfizer, through its wholly owned subsidiary Eclipse Acquisition, has completed the acquisition of biopharmaceutical company Icagen.

Pfizer’s pipeline specialisation

In early 2018 Pfizer announced it would be ending its neuroscience discovery program.

Pfizer Genotropin Manufacturing, Strangnas

Pfizer is one of the largest pharmaceutical companies in the world. Recent restructuring has led to the company putting more...

Pfizer R&D Facility

Pfizer's New London facility is a world-class research and development (R&D) centre located in the State of Connecticut in New...

Pfizer to acquire InnoPharma for $360m

Pfizer has entered into an agreement to acquire US-based pharmaceutical development company InnoPharma for $360m.

Pfizer acquires Excaliard Pharmaceuticals

Pfizer has completed the acquisition of Excaliard Pharmaceuticals, a US biopharma company focused on developing drugs for the treatment of skin fibrosis.

Pfizer to shun mega-mergers

US Pharmaceutical giant Pfizer will steer clear of mega-mergers for the foreseeable future, the company's chief executive Ian Read told delegates at the JP Morgan Global Healthcare Conference in San Francisco, California, US.

Pfizer to buy Excaliard Pharmaceuticals

Pfizer has entered into a definitive agreement to acquire Excaliard Pharmaceuticals, gaining access to EXC 001, a skin scarring treatment.

Pfizer Settles Neurontin Suit

Pfizer has settled a dispute with Teva Pharmaceuticals regarding generic versions of epilepsy drug Neurontin, ending a federal court trial. Pfizer had claimed that Teva and its Ivax unit produced copies of the drug that infringed on a patent that does not expire until 2017. <

Pfizer to buy Hospira for $17bn

US-based drug maker Pfizer has signed a merger agreement to acquire injectable drugs and infusion technologies provider Hospira for around $17bn.

Pfizer Withdraws Hypertension Drug

Pfizer has voluntarily withdrawn pulmonary arterial hypertension drug Thelin (sitaxentan), after it was found to be associated with a risk of liver injury. Thelin will be withdrawn in all regions where it is approved – the European Union, Canada and Australia – and further clinical stu

Pfizer to Acquire King Pharmaceuticals

New York-based drug major Pfizer is to acquire King Pharmaceuticals in a $3.6bn deal. The deal will strengthen the company's portfolio before the expiry of key patents next year, including its key cholesterol fighter Lipitor, and provide a bigger share in the prescription pain relief

Pfizer Considers Capsugel Sale

US-based pharmaceutical major Pfizer is considering the sale of its Capsugel business, responsible for the manufacture of capsules and other drug-delivery systems. The company said the move came as part of its review of businesses, with Capsugel, bought for $740m in 2009, considered

Pfizer Suspends Tanezumab Trials

Pfizer has suspended two studies in its clinical programme for investigational compound tanezumab at the request of the US Food and Drug Administration (FDA). The FDA asked that the trials – one for chronic low back pain and the other for painful diabetic peripheral neuropathy – be su

Pfizer and the Business of Being Good

Adam Burns talks to Pfizer regional president of worldwide pharmaceuticals Jorge Puente to see how the company turned its business ethos around for the better.

Pfizer to split into three businesses

Pfizer has revealed plans to reorganise into the company into three different businesses, namely Innovative Medicines, Established Medicines, and Consumer Healthcare.

Pfizer to Continue Japanese Collaboration

Pfizer has announced that it will continue its agreement with Japan's Eisai to provide Aricept to patients suffering from Alzheimer's disease. The decision resolves previous marketing disputes after the companies agreed to continue marketing together in the US and select EU markets, while

Pfizer Completes Wyeth Takeover

Pfizer has announced that it has completed its acquisition of Wyeth, adding a raft of new human, animal, and consumer health vaccines, biologics and nutritional products to its stable. Pfizer chairman and chief executive officer Jeffrey B Kindler said that Pfizer's newly strengthened com

Pfizer Biotech Manufacturing Facility, Shanbally

In mid-2007 it was reported that Pfizer, one of the largest pharmaceutical companies present in the Republic of Ireland, was...